STERLING NEWCASTLE LIMITED

Active Cramlington

Other research and experimental development on natural sciences and engineering

19 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
S

STERLING NEWCASTLE LIMITED

Other research and experimental development on natural sciences and engineering

Founded 8 Apr 2002 Active Cramlington, England 19 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering

Previous Company Names

NEWCHEM TECHNOLOGIES LIMITED 10 May 2002 — 13 May 2024
HANDLEVER LIMITED 8 Apr 2002 — 10 May 2002
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 14 Apr 2026 Next due 21 Apr 2027 11 months remaining
Net assets £2M £300K 2024 year on year
Total assets £2M £337K 2024 year on year
Total Liabilities £149K £37K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Sterling Place Dudley Cramlington Northumberland NE23 7QG England

Website

www.example.com

Full company profile for STERLING NEWCASTLE LIMITED (04411457), an active life sciences and medical technology company based in Cramlington, England. Incorporated 8 Apr 2002. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

£160.01k

Increased by £25.48k (+19%)

Net Assets

£2.15M

Decreased by £300.32k (-12%)

Total Liabilities

£148.80k

Decreased by £36.86k (-20%)

Turnover

£903.31k

Decreased by £1.13M (-56%)

Employees

19

Decreased by 1 (-5%)

Debt Ratio

6%

Decreased by 1 (-14%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Rotthier, KarlDirectorBelgianBelgium593 Nov 2025Active

Shareholders

Shareholders (7)

Sterling Pharma Solutions Limited
100.0%
2,000
Sheila Pamela Golding
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Active
Notified 12 Oct 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Professor Bernard Thomas Golding

Ceased 6 Oct 2023

Ceased

Robert Graham Tyson

Ceased 12 Oct 2023

Ceased

Group Structure

Group Structure

STERLING NEWCASTLE LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
14 Apr 2026Confirmation StatementConfirmation statement made on 7 Apr 2026 with no updates
18 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
18 Dec 2025AccountsAnnual accounts filed
14 Nov 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/03/25
14 Nov 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/03/25
14 Apr 2026 Confirmation Statement

Confirmation statement made on 7 Apr 2026 with no updates

18 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

18 Dec 2025 Accounts

Annual accounts filed

14 Nov 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/03/25

14 Nov 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

Recent Activity

Latest Activity

Confirmation statement made on 7 Apr 2026 with no updates

4 weeks ago on 14 Apr 2026

Annual accounts made up to 31 Mar 2025

4 months ago on 18 Dec 2025

Annual accounts filed

4 months ago on 18 Dec 2025

Audit exemption statement of guarantee by parent company for period ending 31/03/25

5 months ago on 14 Nov 2025

Notice of agreement to exemption from audit of accounts for period ending 31/03/25

5 months ago on 14 Nov 2025